Predict your next investment

CharlestonPharma company logo
HEALTHCARE | Drug Development
charlestonpharma.com

See what CB Insights has to offer

Stage

Unattributed VC | Alive

Total Raised

$1.6M

About CharlestonPharma

CharlestonPharma is focused on developing therapeutic antibodies and related diagnostic tests for cancer patients and healthcare providers. With an exclusive worldwide license from the Medical University of South Carolina (MUSC) for eight specific antibodies as well as the process to make additional fully-human antibodies to this target and worldwide exclusive licenses to the method of treating cancer with an anti-nucleolin antibody and the method for for the diagnosis and prognosis of malignant disease which includes the detection of nucleolin in the cell surface of a patient's tumor cells tissue biopsy, the company is focused on demonstrating preclinical proof of concept for our anti-nucleolin monoclonal antibodies.

CharlestonPharma Headquarter Location

645 Meeting Street Suite 4

Charleston, South Carolina, 29403,

United States

843-789-5907

Latest CharlestonPharma News

CharlestonPharma LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250

Jul 28, 2018

Summary CharlestonPharma LLC CharlestonPharma is a pharmaceutical company that develops antinucleolin antibodies for the treatment of cancer . The company uses in vitro, ex vivo and in vivo proof of concept for its firstinclass fully human monoclonal antibodies that targets nucleolin located in the plasma membrane and cytoplasm of tumor cells. CharlestonPharma's lead candidate CP101.2C8 is a therapeutic candidate with the potential to treat a broad range of solid tumors which include breast, prostate, lung, colon, and pancreas and hematological malignancies; identifify and validate a unique therapeutic target in oncology and to develop first in class fully human monoclonal antibodies that bind specifically to this target. The company has research collaborations with Medical University of South Carolina and University of Louisville. CharlestonPharma is headquartered in Charleston, South Carolina, the US. CharlestonPharma LLC Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CharlestonPharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CharlestonPharma is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

5,238 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CharlestonPharma Patents

CharlestonPharma has filed 1 patent.

The 3 most popular patent topics include:

  • Biological warfare
  • Biological warfare facilities
  • Biotechnology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/7/2017

Biological warfare, Biotechnology, Biological warfare facilities, Legal terminology, Rights

Application

Application Date

3/7/2017

Grant Date

Title

Related Topics

Biological warfare, Biotechnology, Biological warfare facilities, Legal terminology, Rights

Status

Application

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.